US Stock Movement | Biotechnology company City Therapeutics (CTY.US) debuts on the US stock market, rising nearly 24% after opening

智通财经2026/10/16 17:42

Show original

As of press time, the stock has risen nearly 24%, trading at $22.315.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to Zhihui Finance APP, on Friday, City Therapeutics (CTY.US) debuted on the US stock market. As of press time, the stock had risen nearly 24% to $22.315. The IPO price was $18. City Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, USA. Founded in 2023, it focuses on developing next-generation RNA interference (RNAi) therapies, treating diseases with significant unmet medical needs by inhibiting the expression of specific proteins associated with disease. The company's core research and development pipeline includes CITY-FXI for the prevention of thromboembolic diseases, CITY-RBP4 for treating the hereditary retinal disease Stargardt disease, and CITY-TFR2 targeting anemia related to chronic diseases, among which CITY-FXI has already entered Phase I clinical trials. The company was founded by experts in the RNAi field. John Maraganore, co-founder and executive chairman, previously served as CEO of RNAi pharmaceutical pioneer Alnylam.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.

华尔街见闻•2026/10/16 22:46